References
- Gambrell RD Jr. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Fertil Steril 1982: 37(4): 457–74
- Hammond CB, Maxson WS. Current status of estrogen therapy for the menopause. Fertil Steril 1982: 37(1): 5–25
- Tataryn IV, Lomax P, Meldrum DR, et al. Objective techniques for the assessment of postmenopausal hot flashes. Obstet Gynecol 1981: 57(3): 340–4
- Meldrum DR, Erlik Y, Lu JK, et al. Objectively recorded hot flushes in patients with pituitary insufficiency. J Clin Endocrinol Metab 1981: 52(4): 684–8
- Erlik Y, Tataryn IV, Meldrum DR, et al. Association of waking episodes with menopausal hot flushes. JAMA 1981: 245(17): 1741–4
- Utian WH. The mental tonic effect of oestrogens administered to oöphorectomized females. S Afr Med J 1972: 46 (Aug 5): 1079–82
- Meema S, Meema HE. Menopausal bone loss and estrogen replacement. Isr J Med Sci 1976: 12(7): 601–6
- Lindsay R, Hart DM, Aitken JM, et al. Long-term prevention of postmenopausal osteoporosis by oestrogen: evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976: 1(7968): 1038–41
- Christiansen C, Christensen MS, Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981: 1(8218): 459–61
- Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 1977: 62(5): 707–14
- Hammond CB, Jelovsek FR, Lee KL, et al. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol 1979: 133(5): 525–36
- Walter S, Jensen HK. The effect of treatment with oestradiol and oestriol on fasting serum cholesterol and triglyceride levels in postmenopausal women. Br J Obstet Gynaecol 1977: 84(11): 869–72
- Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Surgically confirmed gallbladder disease, venous thromboembolism and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med 1974: 290 (Jan 3): 15–9
- Wallentin L, Larsson-Cohn U. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids. Acta Endocrinol (Copenh) 1977: 86(3): 597–607
- Hirvonen E, Mälkönen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981: 304(10): 560–3
- Nachtigall LE, Nachtigall RH, Nachtigall RD, et al. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979: 53(3): 277–81
- Geola FL, Frumar AM, Tataryn IV, et al. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1980: 51(3): 620–5
- Lindsay R, Hart DM, MacLean A, et al. Bone response to termination of oestrogen treatment. Lancet 1978: 1(8078): 1325–7
- Yen SS, Jaffe RB. Reproductive endocrinology: physiology, pathophysiology, and clinical management. Philadelphia: WB Saunders.1978: 427